Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART).
Michele PighiFabrizio TomaiSimone FezziGabriele PesariniAlessandro PetroliniLeonardo SpedicatoGiuseppe TarantiniMarco FerliniPaolo CalabròBruno LoiValeria FerreroMaria Natalia Tovar ForeroJoost DaemenFlavio RibichiniPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2024)
BRS-based PCI for the treatment of CAV is feasible and safe, with an ISSR incidence similar to what reported in retrospective studies with drug-eluting stents.
Keyphrases
- coronary artery disease
- acute myocardial infarction
- percutaneous coronary intervention
- acute coronary syndrome
- left ventricular
- risk factors
- cross sectional
- antiplatelet therapy
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- case control
- kidney transplantation
- adverse drug
- replacement therapy